The Treatment of Ewing???s Sarcoma of Bone at the University of Florida: 1969 to 1998
Authors:
- B. Hudson BerreyBBB. Hudson Berrey
- John Graham-PoleJGJohn Graham-Pole
- Nancy Price MendenhallNMNancy Price Mendenhall
- Mark T. ScarboroughMSMark T. Scarborough
- 1 April 2002
- journal article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 397 (397) , 290-297
Abstract
Since 1969, 144 patients with previously untreated Ewing's sarcoma of bone were entered in prospective protocols at the University of Florida. From 1969 through 1981, three institutional protocols were used, and some patients were entered into the First Intergroup Ewing's Sarcoma Study. Starting in 1982, an attempt was made to intensify treatment, with patients divided according to their primary tumor size into standard-risk (< or = 8 cm in maximum diameter) and high-risk groups. Patients with metastases at diagnosis also were considered high risk. The standard-risk protocols (Number 1 and Number 2 specified treatment with chemotherapy considered to be standard for the era; the patients who were high risk had standard chemotherapy followed by end-intensification. Treatment for patients with metastases at diagnosis was intensified additionally in 1993 with a protocol (high-risk protocol Number 5) specifically designed just for these patients. The absolute survival rate of all patients treated before 1982 was 50% at 5 years for patients without metastases at diagnosis and 18% for patients with metastases. Patients with small primary lesions had a better survival rate than patients with large primary lesions. After 1982, the 5-year survival rate for patients treated on the standard-risk protocols was 53% (1985-1998), whereas for high-risk protocols the 5-year survival rate was 63%. Survival rates were better for younger patients at diagnosis and for patients who responded well to induction chemotherapy, indicating that future trials may need to tailor therapy based on the response to induction chemotherapy.Keywords
This publication has 19 references indexed in Scilit:
- Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study GroupJournal of Clinical Oncology, 2000
- A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremitiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.Journal of Clinical Oncology, 1993
- Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.Journal of Clinical Oncology, 1990
- Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: local control and patterns of failureRadiotherapy and Oncology, 1989
- Therapy for localized Ewing's sarcoma of bone.Journal of Clinical Oncology, 1989
- Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescentsJournal of Cancer Research and Clinical Oncology, 1987
- The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy.Journal of Clinical Oncology, 1983
- Localized ewing's sarcoma—treatment and resultsCancer, 1974